Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

UPMC, Google Health, CMU and dbMotion develop novel PHR technology

The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.

2 Mar 2010

Individuals having greater purpose in lives less likely to develop Alzheimer's disease: Study

Individuals who report having greater purpose in their lives appear less likely to develop Alzheimer's disease or its precursor, mild cognitive impairment, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Mar 2010

Long-time cannabis use linked to psychosis-related outcomes

Young adults who have used cannabis or marijuana for a longer period of time appear more likely to have hallucinations or delusions or to meet criteria for psychosis, according to a report posted online today that will appear in the May print issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Mar 2010

Association between depression and obesity bidirectional

Obesity appears to be associated with an increased risk of depression, and depression also appears associated with an increased risk of developing obesity, according to a meta-analysis of previously published studies in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Mar 2010

Study indicates GABA neurotransmitters could play a key role in major depressive disorder

The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.

2 Mar 2010

Scopolamine drug: A rapid-acting antidepressant for depression symptoms

Conventional antidepressant treatments generally require three to four weeks to become effective, thus the discovery of treatments with a more rapid onset is a major goal of biological psychiatry. The first drug found to produce rapid improvement in mood was the NMDA glutamate receptor antagonist, ketamine.

1 Mar 2010

Neurogenesis linked to drug addiction and relapse

Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.

27 Feb 2010

Genetic factors influence likelihood of developing PTSD

The 1994 genocide in Rwanda resulted in the mass killing of up to one million people over the course of about 100 days. Although the exact death toll is unknown, experts estimate that as much as 20% of the country's entire population was murdered. There can be no doubt or surprise then that some of the survivors developed posttraumatic stress disorder, or PTSD, an anxiety disorder that can develop after witnessing or experiencing a traumatizing event, such as abuse, war, or natural disaster.

26 Feb 2010

Schizophrenia: Insight into late development of symptoms

In reports of two new studies, researchers led by Johns Hopkins say they have identified the mechanisms rooted in two anatomical brain abnormalities that may explain the onset of schizophrenia and the reason symptoms don't develop until young adulthood. Both types of anatomical glitches are influenced by a gene known as DISC1, whose mutant form was first identified in a Scottish family with a strong history of schizophrenia and related mental disorders. The findings could lead to new ways to treat, prevent or modify the disorder or its symptoms.

26 Feb 2010

Fetuses exposed to high levels of stress hormone may have solving problems later on: Study

A mother's nurture may provide powerful protection against risks her baby faces in the womb, according to a new article published online today in the journal Biological Psychiatry. The research shows that fetuses exposed to high levels of stress hormone - shown to be a harbinger for babies' poor cognitive development - can escape this fate if their mothers provide them sensitive care during infancy and toddler-hood.

26 Feb 2010

Exergames improve mood and mental health-related quality of life in seniors with SSD

Research at the Sam and Rose Stein Institute for Research on Aging at the University of California, San Diego School of Medicine suggests a novel route to improving the symptoms of subsyndromal depression (SSD) in seniors through the regular use of "exergames" - entertaining video games that combine game play with exercise. In a pilot study, the researchers found that use of exergames significantly improved mood and mental health-related quality of life in older adults with SSD.

26 Feb 2010

The Coalition for Evidence-Based Policy selects Botvin LST as "Top Tier" program

Botvin LifeSkills Training has been selected as a "Top Tier" program by The Coalition for Evidence-Based Policy. The Top Tier initiative, which is being followed closely by Congress, focuses on identifying and validating social programs meeting the highest standard of evidence of effectiveness.

25 Feb 2010

InTouch Health's Remote Presence telemedicine network: Over 100,000 clinical sessions performed

InTouch Health® announced today that it has surpassed 100,000 clinical sessions performed through its Remote Presence telemedicine network. InTouch Health provides comprehensive telehealth solutions that allow physicians to remotely perform complete and real-time consults with hospital patients.

25 Feb 2010

Recovery of consciousness in traumatic brain injury patients

The recovery of consciousness following traumatic brain injury and recent advances in neuroimaging and deep brain stimulation will be discussed at the 14th Annual Swartz Foundation Mind/Brain Lecture at Stony Brook University on Monday, March 15, 2010 at 4:30 p.m. in the Staller Center for the Arts.

25 Feb 2010

Study challenges psychiatrists' official diagnostic manual in preventing mistaken diagnoses of depression

A study in the March edition of the American Journal of Psychiatry senior-authored by Jerome C. Wakefield, a professor at the Silver School of Social Work at New York University with Mark Schmitz of Temple University and Judith Baer of Rutgers University, empirically challenges the effectiveness of psychiatrists' official diagnostic manual in preventing mistaken, false-positive diagnoses of depression.

25 Feb 2010

Brain implant helps scientists in determining link between brainwave patterns and attention

A paralyzed patient implanted with a brain-computer interface device has allowed scientists to determine the relationship between brain waves and attention.

25 Feb 2010

Fisher Wallace Cranial Stimulator prescribed to patients suffering from depression, anxiety and insomnia

Fisher Wallace Laboratories today announced that two psychiatry professors at Columbia University, Dr. Richard Brown and Dr. Andres San Martin, have prescribed the Fisher Wallace Cranial Stimulator to more than 250 patients suffering from depression, anxiety and insomnia.

25 Feb 2010

Special issue of NeuroRehabilitation journal devoted to HI-BI published

IOS Press announces publication of a special issue of NeuroRehabilitation: An International Journal devoted specifically to hypoxic-ischemic brain injury (HI-BI), a significant disruption of brain function due to a deficient supply of oxygen to the brain.

24 Feb 2010

Combination therapies effective for treating depression

Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.

24 Feb 2010

Elevated cerebrospinal fluid levels of P-tau231 may be an early diagnostic biomarker for Alzheimer's disease

Researchers at NYU School of Medicine have found that elevated cerebrospinal fluid levels of phosphorylated tau231 (P-tau231), a damaged tau protein found in patients with Alzheimer's disease, may be an early diagnostic biomarker for Alzheimer's disease in healthy adults.

23 Feb 2010

Psychiatry News and Research

Further Reading

UPMC, Google Health, CMU and dbMotion develop novel PHR technology

Individuals having greater purpose in lives less likely to develop Alzheimer's disease: Study

Long-time cannabis use linked to psychosis-related outcomes

Association between depression and obesity bidirectional

Study indicates GABA neurotransmitters could play a key role in major depressive disorder

Scopolamine drug: A rapid-acting antidepressant for depression symptoms

Neurogenesis linked to drug addiction and relapse

Genetic factors influence likelihood of developing PTSD

Schizophrenia: Insight into late development of symptoms

Fetuses exposed to high levels of stress hormone may have solving problems later on: Study

Exergames improve mood and mental health-related quality of life in seniors with SSD

The Coalition for Evidence-Based Policy selects Botvin LST as "Top Tier" program

InTouch Health's Remote Presence telemedicine network: Over 100,000 clinical sessions performed

Recovery of consciousness in traumatic brain injury patients

Study challenges psychiatrists' official diagnostic manual in preventing mistaken diagnoses of depression

Brain implant helps scientists in determining link between brainwave patterns and attention

Fisher Wallace Cranial Stimulator prescribed to patients suffering from depression, anxiety and insomnia

Special issue of NeuroRehabilitation journal devoted to HI-BI published

Combination therapies effective for treating depression

Elevated cerebrospinal fluid levels of P-tau231 may be an early diagnostic biomarker for Alzheimer's disease

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News